The MultiPath technology outperforms current culture-based methods by providing pathogen identification results in 30 minutes and antimicrobial susceptibility test results in 4 hours…directly from patient sample.

The MultiPath analyzer is a fully automated “sample-to-answer” platform. By combining this level of automation with rapid tests, we can perform up to 40 antimicrobial susceptibility tests or 200 identification tests in a single 8-hour shift.

The MultiPath platform is unique in its ability to rapidly identify a broad range of pathogens, detect toxins and biomarkers with high sensitivity, and perform rapid phenotypic antimicrobial susceptibility testing.